SUSAN GOOBIE
Dr. Susan M. Goobie, MD, FRCPC is an Assistant Professor of Anesthesiology, Peri-operative and Pain Medicine and Director of the Clinical Pharmacology and Pharmacokinetics Laboratory at Boston Children’s Hospital, Harvard Medical School. She has clinical and research interests in optimizing care for children having major surgery including craniofacial, scoliosis and neurosurgery. She has developed expert knowledge in blood conservation methods, coagulation disorders and pharmacological research. She investigated the pharmacodynamic and pharmacokinetic profile of tranexamic acid in a randomized double-blinded trial and showed that tranexamic acid significantly reduced blood loss and blood transfusion requirements in craniofacial surgery. This has become standard of care internationally for this patient population. Furthermore, in a novel pharmacokinetic study, she recommended the best dose to maximize efficacy and reduce potential side effects in children having craniofacial surgery. Currently she is studying the efficacy and safety profile of antifibrinolytics for craniosynostosis, idiopathic scoliosis surgery and pediatric trauma. Her research is innovative, as it will shed new insights and provide clinical guidelines into the mechanism of action, optimum dose, efficacy, and safety of antifibrinolytic use for pediatric non-cardiac surgery.
Dr. Goobie shares her clinical and research expertise in the field of pediatric blood management by regularly presenting this work and speaking at international meetings and publishing original research, reviews, chapters and editorial views pertaining to blood conservation techniques and antifibrinolytic use in pediatric surgery. She is a regular reviewer for major anesthesia journals such as Anesthesia and Analgesia, and Pediatric Anesthesia. She is president-elect of the International Pediatric Craniofacial Collaborative Registry and Chair of the Scientific Committee of the Society for the Advancement of Blood Management. She is an internationally recognized expert, co-investigator and consultant on several large multicentre trials in the area of Pediatric Patient Blood Management.Dr. Goobie is from Newfoundland, Canada and lives in Boston with her husband and three children. In her spare time she enjoys cycling, running, skiing and snowboarding.
THORSTEN HAAS
Thorsten Haas, MD, Lecturer is an anesthesiologist who specializes in pediatric anesthesia. Since 4.5 years, Dr. Haas is senior anesthesiologist at the University Children’s Hospital in Zurich, Switzerland. Dr. Haas grew up in Germany and completed his anesthesiology residency in Germany and Austria, where he continued his work as resident at the department of anesthesia in Innsbruck, Austria. Dr. Haas’ research interests include point-of-care coagulation testing, the influence of colloids on hemostasis, and perioperative coagulation management with special focus on pediatric major surgeries. Recent publications include two chapters of the European Guidelines for perioperative bleeding management, a phase IV randomized controlled trial about the ROTEM®-guided administration of fibrinogen in major pediatric surgery, several clinical as well as experimental studies about the use of ROTEM®, perioperative coagulation management in children, and the diagnosis and therapy of dilutional coagulopathy. He is a peer reviewer for multiple major anesthesia journals. From 2007 to 2009, Dr. Haas has worked as medical director in clinical research & development at CSL Behring Marburg, Germany. Dr. Haas is currently member of the European Society of Anaesthesiology Subgroup for Perioperative Coagulation Management.
RICHARD ING
Richard J. Ing MBBCh, FCA (SA) is a graduate of The University of the Witwatersrand Medical School, Johannesburg South Africa where he completed Specialist Anesthesiology training in 1995. He has practiced anesthesia in Johannesburg and Cape Town South Africa, the United States in Durham North Carolina and since 2011 he has been practicing anesthesia in Denver at Children’s Hospital Colorado. His clinical interests are in the care of pediatric and adult congenital heart disease patients for anesthesia. He enjoys teaching and clinical research. His interests include the anesthetic care of patients with cardiomyopathy, pulmonary hypertension, arrhythmias and single ventricle anatomy. Dr Ing is currently an Associate Professor of Anesthesiology in the School of Medicine at the University of Colorado.
PAUL STRICKER
Dr. Stricker’s passion for improving the care of infants and children with craniofacial abnormalities has been the unifying force behind his career. His research and education activities have been centered on two populations: infants undergoing craniofacial reconstruction surgery and children with difficult airways. In the field of pediatric airway management, Dr. Stricker has authored several chapters as well as numerous editorials and peer-reviewed publications. He has lectured and served as a workshop instructor at national and international meetings; he currently serves as the organizing director of the difficult airway workshop at the Society for Pediatric Anesthesia annual meeting. Dr. Stricker’s primary research focus is clinical outcomes research using observational databases in children undergoing craniofacial reconstruction surgery. In one of Dr. Stricker’s initial studies, he showed how blood loss replacement strategy using donor-matched FFP and packed red blood cells reduced blood donor exposures and prevented coagulopathy. In a subsequent work, he demonstrated how implementation of postoperative transfusion thresholds significantly reduced perioperative transfusion.
Following these single institution studies, it became apparent that multi-institutional collaboration is needed to improve the care of this population at a broader level. To meet this need, Dr. Stricker convened a group of pediatric anesthesiologists from the US and Canada and founded the Pediatric Craniofacial Collaborative Group. Dr. Stricker has since led this group in establishing the Pediatric Craniofacial Surgery Perioperative Registry. Currently there are 30 institutions throughout the US and Canada contributing data; the first publications are anticipated in 2016. Dr. Stricker’s goal is to leverage what is learned from this multicenter registry together with the collaborative relationships that he has helped develop to achieve improvements in the care of children undergoing craniofacial reconstruction surgery at a national and international level.
